sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Intravenous Immunoglobulin Market Scope And Analysis

  • Report Code : TIPRE00030117
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 107
Buy Now

Análisis del alcance del informe de mercado de inmunoglobulina intravenosa en América del Norte y oportunidades para 2023-2030

Buy Now

North America Intravenous Immunoglobulin Market Report North America Intravenous Immunoglobulin Market Size and Share North America Intravenous Immunoglobulin Market Scope and Analysis

North America Intravenous Immunoglobulin Market Report Scope

Report Attribute Details
Market size in 2022 US$ 5,042.91 Million
Market Size by 2030 US$ 8,747.81 Million
Global CAGR (2022 - 2030) 7.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Tipo
  • IgG
  • IgA
  • IgM
By Aplicación
  • Enfermedades de inmunodeficiencia
  • polineuropatía desmielinizante inflamatoria crónica
  • púrpura trombocitopénica idiopática
  • neuropatía motora multifocal
  • hipogammaglobulinemia
  • síndrome de Guillain-Barré
  • deficiencia de anticuerpos específicos
  • miopatías inflamatorias
  • miastenia grave
By Canal de distribución
  • farmacia hospitalaria
  • farmacia minorista
By Usuario final
  • hospitales
  • clínicas especializadas
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Market leaders and key company profiles
  • Takeda Pharmaceutical Co Ltd
  • Grifols SA
  • Pfizer Inc
  • ADMA Biologics, Inc
  • Bio Products Laboratory Ltd
  • Octapharma AG
  • Kedrion SpA
  • CSL Ltd
  • LFB Group